Ji Yao Holding Group Co (SZSE:300108) ROCE % : 0.00% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Ji Yao Holding Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ji Yao Holding Group Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.00%.

Ji Yao Holding Group Co ROCE % Historical Data

The historical data trend for Ji Yao Holding Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ji Yao Holding Group Co ROCE % Chart

Ji Yao Holding Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-70.75

-25.69

-60.34

-24.59

-184.19

Ji Yao Holding Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															10.98	-97.37	-47.68	-1,050.47	-

Ji Yao Holding Group Co ROCE % Calculation

Ji Yao Holding Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-284.969	/	( ( (2222.413 - 1929.289)	+	(1913.802 - 1897.497) )	/ 2 )
	=	-284.969	/	( (293.124	+	16.305)	/ 2 )
	=	-284.969	/	154.7145
	=	-184.19 %

Ji Yao Holding Group Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-92.508	/	( ( (1913.802 - 1897.497)	+	(1892.261 - 1940.769) )	/ 2 )
	=	-92.508	/	( ( 16.305	+	-48.508 )	/ 2 )
	=	-92.508	/	-16.1015
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Ji Yao Holding Group Co (SZSE:300108) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ji Yao Holding Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of Ji Yao Holding Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ji Yao Holding Group Co (SZSE:300108) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ji Yao Holding Group Co Ltd (SZSE:300108) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 6, Huancheng North Road, Jilin Province, Meihekou, CHN, 135000

Website

http://www.jiyaogroup.com

Ji Yao Holding Group Co Ltd is a China based company involved in the pharmaceutical industry. It offers Chinese and Western medicines in the areas of pediatrics, phlegm and cough, gynecology, cardiovascular and cerebrovascular, antiviral, urinary, anti-inflammatory, gastrointestinal, tonic class, and rheumatoid immunity.

Executives

You Ke Li	Executives
Xin Da Cheng	Executives
Lu Zhong Kui	Director
Liu Long	Executives
Wang De Heng	Directors, executives
Zhang Liang	Directors, Directors, and Executives
Sun Jun	Directors, executives
Zhang Xin Qiang	Director

Ji Yao Holding Group Co (SZSE:300108) Headlines

No Headlines